Hanak Viktor, Golbin Jason M, Hartman Thomas E, Ryu Jay H
Division of Pulmonary, Critical Care, and Sleep, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Chest. 2008 Jul;134(1):133-8. doi: 10.1378/chest.07-3005. Epub 2008 Apr 10.
Histopathologic evidence of fibrosis on surgical lung biopsy has been associated with reduced survival in patients with hypersensitivity pneumonitis (HP). Changes of pulmonary fibrosis detected on CT may also correlate with prognosis in patients with HP.
We identified 69 consecutive patients with HP diagnosed between January 1997 and December 2002 at Mayo Clinic, Rochester, MN. Patients were stratified into fibrotic and nonfibrotic groups based on the CT findings. Fibrosis was defined by the presence of irregular linear opacities, traction bronchiectasis, or honeycombing.
Of 69 patients, 26 were classified as fibrotic and 43 as nonfibrotic. Patients in the fibrotic group were older, had longer symptom duration, were more likely to have crackles on auscultation, more likely to be exposed to avian antigen, and had greater restrictive lung impairment (p<0.05 for all comparisons). There were 11 deaths in the fibrotic group and 1 death in the nonfibrotic group (p<0.0001). In the regression analysis, CT evidence of fibrosis, more severe pulmonary function abnormalities, and the presence of crackles on auscultation were predictive of reduced survival (p<0.05 for all). The presence as well as the extent of fibrosis on CT was associated with increased mortality. The age-adjusted hazard ratio for mortality in patients with fibrosis was 4.6 (95% confidence interval, 2.0 to 20.1; p<0.0001).
CT findings of parenchymal fibrosis are associated with reduced survival in patients with HP and may serve as a useful prognostic indicator.
手术肺活检的纤维化组织病理学证据与过敏性肺炎(HP)患者生存率降低有关。CT检测到的肺纤维化变化也可能与HP患者的预后相关。
我们确定了1997年1月至2002年12月在明尼苏达州罗切斯特市梅奥诊所连续诊断的69例HP患者。根据CT结果将患者分为纤维化组和非纤维化组。纤维化定义为存在不规则线性阴影、牵拉性支气管扩张或蜂窝状改变。
69例患者中,26例被分类为纤维化组,43例为非纤维化组。纤维化组患者年龄更大,症状持续时间更长,听诊时更易出现啰音,更易接触禽类抗原,且肺限制性损害更严重(所有比较p<0.05)。纤维化组有11例死亡,非纤维化组有1例死亡(p<0.0001)。回归分析显示,CT纤维化证据、更严重的肺功能异常以及听诊时出现啰音可预测生存率降低(所有p<0.05)。CT上纤维化的存在及范围与死亡率增加相关。纤维化患者经年龄调整的死亡风险比为4.6(95%置信区间,2.0至20.1;p<0.0001)。
实质性纤维化的CT表现与HP患者生存率降低相关,可作为有用的预后指标。